Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study

Background: Preferentially expressed antigen in melanoma (PRAME) is a cancer testis antigen (CTA) identified in 1997 through analysis of the specificity of tumor-reactive T-cell clones derived from a patient with metastatic cutaneous melanoma. Although at first it seemed even more specific, various...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzato, Gerardo, Mangialardi, Katia, Falcicchio, Giovanni, Colagrande, Anna, Ingravallo, Giuseppe, Arezzo, Francesca, Giliberti, Giovanna, Trilli, Irma, Loizzi, Vera, Lettini, Teresa, Scarcella, Sara, Annese, Tiziana, Parente, Paola, Lupo, Carmelo, Casatta, Nadia, Maiorano, Eugenio, Cormio, Gennaro, Resta, Leonardo, Ribatti, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951616/
https://www.ncbi.nlm.nih.gov/pubmed/35328098
http://dx.doi.org/10.3390/genes13030545

Ejemplares similares

Ejemplares similares